title: Screening for colorectal cancer: possible improvements by risk assessment evaluation?
abstract: Emerging results indicate that screening improves survival of patients with colorectal cancer. Therefore, screening programs are already implemented or are being considered for implementation in Asia, Europe and North America. At present, a great variety of screening methods are available including colono- and sigmoidoscopy, CT- and MR-colonography, capsule endoscopy, DNA and occult blood in feces, and so on. The pros and cons of the various tests, including economic issues, are debated. Although a plethora of evaluated and validated tests even with high specificities and reasonable sensitivities are available, an international consensus on screening procedures is still not established. The rather limited compliance in present screening procedures is a significant drawback. Furthermore, some of the procedures are costly and, therefore, selection methods for these procedures are needed. Current research into improvements of screening for colorectal cancer includes blood-based biological markers, such as proteins, DNA and RNA in combination with various demographically and clinically parameters into a "risk assessment evaluation" (RAE) test. It is assumed that such a test may lead to higher acceptance among the screening populations, and thereby improve the compliances. Furthermore, the involvement of the media, including social media, may add even more individuals to the screening programs. Implementation of validated RAE and progressively improved screening methods may reform the cost/benefit of screening procedures for colorectal cancer. Therefore, results of present research, validating RAE tests, are awaited with interest.
authors.affiliation: Department of Surgical Gastroenterology, Hvidovre Hospital, Hvidovre, Denmark. h.j.nielsen@ofir.dk
authors.forename: Hans J
authors.initials: HJ
authors.lastname: Nielsen
authors.forename: Karen V
authors.initials: KV
authors.lastname: Jakobsen
authors.forename: Ib J
authors.initials: IJ
authors.lastname: Christensen
authors.forename: Nils
authors.initials: N
authors.lastname: Brünner
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood; D015179:Colorectal Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000517:prevention & control; D003710:Demography; D006801:Humans; D008403:Mass Screening / Q000191:economics / Q000379:methods*; D010342:Patient Acceptance of Health Care; D018570:Risk Assessment
chemical_list: D014408:Biomarkers, Tumor